SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-052527
Filing Date
2020-11-09
Accepted
2020-11-09 16:22:33
Documents
60
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 Q3 2020 10-Q arct-10q_20200930.htm 10-Q 1558147
2 EX-10.32 arct-ex1032_97.htm EX-10.32 110888
3 EX-10.33 arct-ex1033_98.htm EX-10.33 442807
4 EX-31.1 arct-ex311_7.htm EX-31.1 18790
5 EX-31.2 arct-ex312_8.htm EX-31.2 18745
6 EX-32.1 arct-ex321_9.htm EX-32.1 8113
7 EX-32.2 arct-ex322_6.htm EX-32.2 8047
  Complete submission text file 0001564590-20-052527.txt   5692745

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT arct-20200930.xml EX-101.INS 794921
9 XBRL TAXONOMY EXTENSION SCHEMA arct-20200930.xsd EX-101.SCH 52240
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE arct-20200930_cal.xml EX-101.CAL 36784
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE arct-20200930_def.xml EX-101.DEF 187595
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE arct-20200930_lab.xml EX-101.LAB 363694
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arct-20200930_pre.xml EX-101.PRE 284960
Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38942 | Film No.: 201297990
SIC: 2834 Pharmaceutical Preparations